SENSITIVE TO LOW PPM AND REVERSIBLE SENSOR FOR CO

对低 PPM 敏感且可逆 CO 传感器

基本信息

  • 批准号:
    7694302
  • 负责人:
  • 金额:
    $ 36.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-15 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): According to the Cincinnati Children's Hospital Medical Center report, carbon monoxide is the leading cause of accidental death by poisoning. More recent estimates reveal 3,500-4,000 people die each year due to accidental CO exposure; and an additional 10,000 seek medical attention. Carbon monoxide exposure is especially dangerous for unborn babies, infants, and children because they have smaller bodies and faster metabolisms -- they absorb carbon monoxide quicker and at lower levels. Toxic levels of carbon monoxide can be up to ten times higher in the fetus than the mother. Possible mitigation requires a reliable, early warning CO detector. High sensitivity and complete reversibility are two desirable characteristics that are lacking severely in CO detectors currently available in the market. During Phase I, InnoSense LLC has demonstrated a thin film-based CO sensor sensitive to 5 ppm CO responding within five seconds. The sensor has also shown reversibility within five seconds. The Phase II project would: (a) Fine-tune the CO indicator for shortening the response/recovery times by 50% or more, (b) Conduct extensive performance studies to evaluate for how long and how effectively this sensor would perform reliably in the presence of contaminants likely to be found in a typical household. PUBLIC HEALTH RELEVANCE: Sensitive to Low PPM and Reversible Sensor for CO Phase II Project Narrative A key goal of the Phase II project is to fine-tune the CO indicator formulation. The Phase II work builds on the thin film formulation developed during Phase I utilizing ormosil matrix. This formulation strategy along with the fiber bundle approach complements the Principal Investigator's earlier patents covering basic ingredients of the CO indicator. Together, the sensing platform is expected to offer devices that would have multi-analyte detection capability. InnoSense LLC has systematically assembled and developed chemical sensor capabilities, materials science expertise, and home-built optoelectronic test and measurement devices. The company has also assembled a competent scientific team having seventy person-years of experience developing commercially viable sensor products. Given these resources and its commitment to the area of medically relevant sensors, InnoSense LLC is uniquely positioned to make effective use of the Phase II funding to study development of this life-saving device especially for a vulnerable portion of our populace - the elderly, infants and pregnant women carrying the unborn.
描述(由申请人提供):根据辛辛那提儿童医院医疗中心的报告,一氧化碳是中毒意外死亡的主要原因。最近的估计显示,每年有3,500 - 4,000人因意外接触CO而死亡;另有10,000人寻求医疗照顾。一氧化碳暴露对未出生的婴儿,婴儿和儿童特别危险,因为他们的身体较小,新陈代谢较快-他们吸收一氧化碳更快,水平更低。胎儿体内的一氧化碳毒性水平可能比母亲高出十倍。可能的缓解措施需要可靠的早期预警CO探测器。高灵敏度和完全可逆性是目前市场上可用的CO检测器严重缺乏的两个期望特性。在第一阶段,InnoSense LLC已经展示了一种基于薄膜的CO传感器,该传感器对5 ppm CO敏感,在5秒内响应。传感器还显示在5秒内可逆。第二阶段项目将:(a)微调一氧化碳指示器,将响应/恢复时间缩短50%或更多,(B)进行广泛的性能研究,以评估在典型家庭中可能发现的污染物存在的情况下,该传感器将可靠地工作多久和有效程度如何。公共卫生相关性:第二阶段项目的一个关键目标是微调一氧化碳指标的制定。第二阶段的工作是建立在第一阶段利用ormosil基质开发的薄膜配方基础上的。这种配方策略沿着纤维束方法补充了主要研究者的早期专利,涵盖了CO指示剂的基本成分。总之,传感平台预计将提供具有多分析物检测能力的设备。InnoSense LLC系统地组装和开发了化学传感器功能,材料科学专业知识和自制光电测试和测量设备。该公司还组建了一支有能力的科学团队,拥有70年开发商业上可行的传感器产品的经验。鉴于这些资源及其对医疗相关传感器领域的承诺,InnoSense LLC处于独特的地位,可以有效利用第二阶段资金来研究这种救生设备的开发,特别是针对我们人口中的弱势群体-老年人,婴儿和孕妇携带未出生的婴儿。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kisholoy Goswami其他文献

Kisholoy Goswami的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kisholoy Goswami', 18)}}的其他基金

FIBER GRATING-BASED CHEMOSELECTIVE AND REVERSIBLE SENSOR ARRAY
基于光纤光栅的化学选择性和可逆传感器阵列
  • 批准号:
    7294883
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
FIBER GRATING-BASED CHEMOSELECTIVE AND REVERSIBLE SENSOR ARRAY
基于光纤光栅的化学选择性和可逆传感器阵列
  • 批准号:
    7473905
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
FIBER GRATING-BASED CHEMOSELECTIVE AND REVERSIBLE SENSOR ARRAY
基于光纤光栅的化学选择性和可逆传感器阵列
  • 批准号:
    7222631
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
SENSITIVE TO LOW PPM AND REVERSIBLE SENSOR FOR CO
对低 PPM 敏感且可逆 CO 传感器
  • 批准号:
    7611070
  • 财政年份:
    2004
  • 资助金额:
    $ 36.54万
  • 项目类别:
SENSITIVE TO LOW PPM AND REVERSIBLE SENSOR FOR CO
对低 PPM 敏感且可逆 CO 传感器
  • 批准号:
    7767273
  • 财政年份:
    2004
  • 资助金额:
    $ 36.54万
  • 项目类别:
Sensitive to Low PPM and Reversible Sensor for CO
对低 PPM 敏感的 CO 可逆传感器
  • 批准号:
    6790353
  • 财政年份:
    2004
  • 资助金额:
    $ 36.54万
  • 项目类别:
FLUORESCENCE ENERGY TRANSFER IMMUNOASSAY FOR PATHOGENS
病原体荧光能量转移免疫测定
  • 批准号:
    2040449
  • 财政年份:
    1996
  • 资助金额:
    $ 36.54万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了